Key Market Indicators
Sales of digestive system disorder medicine in the UK are set to reach £2.8 billion by 2026. This is an increase of 0.8% per year on average, since 1989. In 2021, the UK was in seventh place in the world rankings, with Italy overtaking it with sales of £2.7 billion. Japan, South Korea and Canada followed in second, third and fourth place respectively.